Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2005-05-17 (20 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: FOURCHAMBAULT (58600), Nievre
SELARL PHARMACIE DE LA BRASSERIE : revenue, balance sheet and financial ratios
SELARL PHARMACIE DE LA BRASSERIE is a French company
founded 20 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in FOURCHAMBAULT (58600),
this company of category PME
shows in 2018 a revenue of 2.5 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE DE LA BRASSERIE (SIREN 482451424)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
2 492 190 €
2 431 456 €
N/C
Net income
120 510 €
168 306 €
175 016 €
183 425 €
178 399 €
118 762 €
99 618 €
151 005 €
137 809 €
217 238 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
247 658 €
232 933 €
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
6.1%
5.7%
N/C
Revenue and income statement
In 2025, SELARL PHARMACIE DE LA BRASSERIE generates positive net income of 121 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 217 k€ -> 121 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
120 510 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 3%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 84%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
3.297%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
83.84%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELARL PHARMACIE DE LA BRASSERIE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
13.909
22.426
22.026
18.288
19.758
22.861
26.479
23.526
15.525
3.297
Financial autonomy
80.811
71.208
72.959
74.571
74.629
74.997
72.376
74.894
78.806
83.84
Repayment capacity
None
2.576
2.168
None
None
None
None
None
None
None
Cash flow / Revenue
None%
6.547%
7.782%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
3.32025
2023
2024
2025
Q1: 13.57
Med: 49.47
Q3: 128.28
Excellent
In 2025, the debt ratio of SELARL PHARMACIE DE LA BR... (3.30) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
83.84%2025
2023
2024
2025
Q1: 33.69%
Med: 53.88%
Q3: 72.26%
Excellent+9 pts over 3 years
In 2025, the financial autonomy of SELARL PHARMACIE DE LA BR... (83.8%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 192.31. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
192.308
Liquidity indicators evolution SELARL PHARMACIE DE LA BRASSERIE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
480.639
159.57
198.07
162.094
204.282
328.084
354.204
381.259
284.131
192.308
Interest coverage
None
0.803
0.78
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
192.312025
2023
2024
2025
Q1: 131.48
Med: 182.6
Q3: 258.72
Good-22 pts over 3 years
In 2025, the liquidity ratio of SELARL PHARMACIE DE LA BR... (192.31) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELARL PHARMACIE DE LA BRASSERIE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
0 €
275 314 €
263 574 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
0
34
35
0
0
0
0
0
0
0
Customer payment term (days)
0
8
9
0
0
0
0
0
0
0
Supplier payment term (days)
0
51
42
0
0
0
0
0
0
0
Positioning of SELARL PHARMACIE DE LA BRASSERIE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of SELARL PHARMACIE DE LA BRASSERIE is estimated at
1 914 315 €
(range 1 299 063€ - 3 003 824€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1299k€1914k€3003k€
1 914 315 €Range: 1 299 063€ - 3 003 824€
NAF 5 année 2025
Valuation method used
Net Income Multiple
120 510 €
×
15.9x
=1 914 316 €
Range: 1 299 064€ - 3 003 825€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE DE LA BRASSERIE with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE DE LA BRASSERIE
What is the revenue of SELARL PHARMACIE DE LA BRASSERIE ?
The revenue of SELARL PHARMACIE DE LA BRASSERIE in 2018 is 2.5 M€.
Is SELARL PHARMACIE DE LA BRASSERIE profitable?
Yes, SELARL PHARMACIE DE LA BRASSERIE generated a net profit of 121 k€ in 2025.
Where is the headquarters of SELARL PHARMACIE DE LA BRASSERIE ?
The headquarters of SELARL PHARMACIE DE LA BRASSERIE is located in FOURCHAMBAULT (58600), in the department Nievre.
Where to find the tax return of SELARL PHARMACIE DE LA BRASSERIE ?
The tax return of SELARL PHARMACIE DE LA BRASSERIE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE DE LA BRASSERIE operate?
SELARL PHARMACIE DE LA BRASSERIE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart